×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| GENNEX LABORATORIES LTD. | NA | NA | NA | NA | 257.0 | 15.7 |
| AMBALAL SARABHAI ENTERPRISES L | NA | NA | NA | NA | 251 | 13.4 |
| ASARFI HOSPITAL LIMITED | NA | NA | NA | NA | 244 | 23.7 |
Gennex Laboratories Ltd, with Security Code 531739, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 13.9 | 18.2 | 14.1 | 14.2 | 17.1 | 21.3 | 21.3 | 24.7 | 25.3 | 23.3 |
| Expenses | 12.8 | 16.9 | 10.2 | 10.3 | 15.6 | 18.2 | 18.4 | 21.0 | 21.8 | 23.1 |
| Operating Profit | 1.1 | 1.3 | 3.9 | 4.0 | 1.4 | 3.1 | 2.9 | 3.7 | 3.5 | 0.1 |
| OPM % | 7.86% | 7.01% | 27.69% | 27.88% | 8.41% | 14.51% | 13.71% | 15.01% | 13.83% | 0.61% |
| Other Income | 0.7 | 1.6 | 0.0 | 0.1 | 2.2 | 2.0 | 2.5 | 1.8 | 2.1 | 2.9 |
| Interest | 0.2 | 0.5 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.5 | 0.4 | 0.5 |
| Depreciation | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.2 | 0.2 |
| Profit before tax | 1.4 | 2.2 | 3.4 | 3.5 | 3.2 | 4.6 | 4.9 | 5.0 | 5.0 | 2.3 |
| Tax % | -25.2% | -22.3% | -25.3% | -25% | -16.5% | -14.7% | -15.3% | -17% | -15.1% | -27.6% |
| Net Profit | 1.1 | 1.7 | 2.6 | 2.7 | 2.6 | 3.9 | 4.2 | 4.2 | 4.2 | 1.5 |
| EPS in Rs | 0.07 | 0.1 | 0.15 | 0.15 | 0.15 | 0.22 | 0.18 | 0.18 | 0.19 | 0 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 13.9 | 18.7 | 16.5 | 17.6 | 19.1 | 33.5 | 28.3 | 31.5 | 37.7 | 40.3 |
| Expenses | 12.8 | 17.3 | 11.4 | 12.4 | 16.6 | 29.3 | 24.1 | 25.9 | 32.9 | 38.5 |
| Operating Profit | 1.1 | 1.4 | 5.1 | 5.2 | 2.5 | 4.2 | 4.2 | 5.6 | 4.9 | 1.9 |
| OPM % | 7.86% | 7.41% | 30.73% | 29.42% | 13.29% | 12.68% | 14.93% | 17.82% | 12.87% | 4.63% |
| Other Income | 0.7 | 2.1 | 0.0 | 0.6 | 2.3 | 2.0 | 2.5 | 1.8 | 2.3 | 3.8 |
| Interest | 0.2 | 0.6 | 0.7 | 0.8 | 0.8 | 0.7 | 0.7 | 1.1 | 0.8 | 1.2 |
| Depreciation | 0.2 | 0.4 | 0.6 | 1.0 | 0.5 | 0.2 | 0.5 | 0.2 | 0.5 | 0.5 |
| Profit before tax | 1.4 | 2.5 | 3.7 | 4.0 | 3.5 | 5.3 | 5.5 | 6.1 | 5.8 | 4.0 |
| Tax % | -25.2% | -19.1% | -23.4% | -22.4% | -21.4% | -15.2% | -15.4% | -12.3% | -12.9% | -20.2% |
| Net Profit | 1.1 | 2.0 | 2.9 | 3.1 | 2.8 | 4.5 | 4.7 | 5.4 | 5.1 | 3.1 |
| EPS in Rs | 0.07 | 0.12 | 0.16 | 0.17 | 0.16 | 0.14 | 0.21 | 0.21 | 0.22 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 4% |
| 3 Years: | 4% |
| TTM: | 47% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 50% |
| 5 Years: | 40% |
| 3 Years: | 40% |
| TTM: | 73% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 40% |
| 3 Years: | 26% |
| 1 Year: | -25% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 9% |
| 3 Years: | 13% |
| TTM: | 82% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 42% |
| 3 Years: | 43% |
| TTM: | 77% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 40% |
| 3 Years: | 26% |
| 1 Year: | -25% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|